Lexston Mining Corporation Announces Fieldwork on Dory Property and two Marketing Agreements Biotech Investing
Republic Technologies Inc. Announces Up to US$100 Million Proposed Secured Convertible Note Facility Financing Medical Device Investing
CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO Pharmaceutical Investing
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director Biotech Investing
Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference Life Science Investing
Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Biotech Investing
Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities Biotech Investing
RINVOQ® Demonstrated Superiority Versus HUMIRA® for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor Pharmaceutical Investing
